This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Menopause  • Alert me on articles by topic

Rebecca Voelker

JAMA. 2005;293:2329-2331.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Nearly 3 years after findings from the Women’s Health Initiative (WHI) threw a major wrench into menopausal hormone use, a panel convened by the National Institutes of Health has taken a first step toward determining safe, effective approaches in managing symptoms of menopause.

Panel chair Carol Mangione, MD, said confusion has flooded discussions of managing menopausal symptoms since the WHI findings showed that estrogen only and estrogen plus progestin therapy can increase the risk of coronary heart disease, thromboembolism, stroke, and breast cancer.

"The information out there has not been sufficient for patients to understand the implications of [the WHI] and how the results should apply to their personal decisions," said Mangione, a professor of medicine in the David Geffen School of Medicine at the University of California, Los Angeles.

Many women stopped using hormones after the WHI findings came out, Mangione noted, even though the landmark study . . . [Full Text of this Article]

NORMAL PART OF LIFE

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quality or Quantity in the Management of Hereditary Ovarian Cancer Risk: Is It Really a Trade-Off?
Masciari and Garber
JCO 2005;23:6817-6819.
FULL TEXT